Skip to main content
Log in

Building and validation of a prognostic model for predicting extracorporeal circuit clotting in patients with continuous renal replacement therapy

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

To develop a predictive model for circuit clotting in patients with continuous renal replacement therapy (CRRT).

Methods

A total of 425 cases were selected. 302 cases were used to develop a predictive model of extracorporeal circuit life span during CRRT without citrate anticoagulation in 24 h, and 123 cases were used to validate the model. The prediction formula was developed using multivariate Cox proportional-hazards regression analysis, from which a risk score was assigned.

Results

The mean survival time of the circuit was 15.0 ± 1.3 h, and the rate of circuit clotting was 66.6 % during 24 h of CRRT. Five significant variables were assigned a predicting score according to the regression coefficient: insufficient blood flow, no anticoagulation, hematocrit ≥0.37, lactic acid of arterial blood gas analysis ≤3 mmol/L and APTT < 44.2 s. The Hosmer–Lemeshow test showed no significant difference between the predicted and actual circuit clotting (R 2 = 0.232; P = 0.301).

Conclusions

A risk score that includes the five above-mentioned variables can be used to predict the likelihood of extracorporeal circuit clotting in patients undergoing CRRT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ronco C, Bellomo R, Ricci Z (2001) Continuous renal replacement therapy in critically ill patients. Nephourol Dial Transplant 16(Suppl 5):67–72

    Article  Google Scholar 

  2. Uchino S, Bellomo R, Morimatsu H et al (2007) Continuous renal replacement therapy: a worldwide practice survey. Intensive Care Med 33:1563–1570

    Article  PubMed  Google Scholar 

  3. Vanholder R, Van Biesen W, Lameire N (2001) What is the renal replacement method of first choice for intensive care patients? J Am Soc Nephourol 12(suppl 17):S40–S43

    Google Scholar 

  4. Kleger G, Fassler E (2010) Can circuit lifetime be a quality indicator in continuous renal replacement therapy in the critically ill? Int J Artif Organs 33:139–146

    PubMed  Google Scholar 

  5. Wald R, Friedrich JO, Bagshaw SM et al (2012) Optimal Mode of clearance in critically ill patients with Acute Kidney Injury (OMAKI)-a pilot randomized controlled trial of hemofiltration versus hemodialysis: a Canadian Critical Care Trials Group project. Crit Care 16:R205

    Article  PubMed Central  PubMed  Google Scholar 

  6. Kim B, Fealy N, Baldwin I, Bellomo R (2011) Insertion side, body position and circuit life during continuous renal replacement therapy with femoral vein access. Blood Purif 31:42–46

    Article  PubMed  Google Scholar 

  7. Joannidis M, Oudemans-van Straaten HM (2007) Clinical review: patency of the circuit in continuous renal replacement therapy. Crit Care 11:218

    Article  PubMed Central  PubMed  Google Scholar 

  8. Cutts MW, Thomas AN, Kishen R (2000) Transfusion requirements during continuous veno-venous haemofiltration: the importance of filter life. Intensive Care Med 26:1694–1697

    Article  PubMed  CAS  Google Scholar 

  9. Webb AR, Mythen MG, Jacobsen D, Mackie IJ (1995) Maintaining blood flow in the extracorporeal circuit: hemostasis and anticoagulation. Intensive Care Med 21:84–93

    Article  PubMed  CAS  Google Scholar 

  10. Hackbarth R, Bunchman TE, Chua AN (2007) The effect of vascular access location and size on circuit survival in pediatric continuous renal replacement therapy: a report from the PPCRRT registry. Int J Artif Organs 30:1116–1121

    PubMed  CAS  Google Scholar 

  11. Baldwin I, Bellomo R, Koch B (2004) Blood flow reductions during continuous renal replacement therapy and circuit life. Intensive Care Med 30:2074–2079

    Article  PubMed  Google Scholar 

  12. Holt A, Bierer P, Bersten A, Bury L, Vedig A (1996) Continuous renal replacement therapy in critically ill patients: monitoring circuit function. Anaesth Intensive Care 24:423–429

    PubMed  CAS  Google Scholar 

  13. Padrini R, Canova C, Conz P, Mancini E, Rizzioli E, Santoro A (2005) Convective and adsorptive removal of β2-microglobulin during predilutional and postdilutional hemofiltration. Kidney Int 68:2331–2337

    Article  PubMed  CAS  Google Scholar 

  14. Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R (2003) Pre-dilution vs. post-dilution during continuous veno-venous hemofiltration: impact on filter life and azotemic control. Nephron Clin Pract 94:c94–c99

    Article  PubMed  Google Scholar 

  15. Unger JK, Haltern C, Portz B, Dohmen B, Gressner A, Rossaint R (2001) Relation of haemofilter type to venous catheter resistance is crucial for filtration performance and haemocompatibility in CVVH–—an in vitro study. Nephourol Dial Transplantat 21:2191–2201

    Article  CAS  Google Scholar 

  16. Zhu LP, Zhang XX, Xu L, Du CH, Zhu BK, Xu YY (2007) Improved protein-adsorption resistance of polyethersulfone membranes via surface segregation of ultrahigh molecular weight poly(styrene-alt-maleic anhydride). Coll Surf B Biointerfaces 57:189–197

    Article  CAS  Google Scholar 

  17. Melly MA, Meng HC, Schaffner W (1975) Microbiol growth in lipid emulsions used in parenteral nutrition. Arch Surg 110:1479–1481

    Article  PubMed  CAS  Google Scholar 

  18. Mershon J, Nogami W, Williams JM, Yoder C, Eitzen HE, Lemons JA (1986) Bacterial/fungal growth in a combined parenteral nutrition solution. JPEN J Parenter Enter Nutr 10:498–502

    Article  CAS  Google Scholar 

  19. Gilbert M, Gallagher SC, Eads M, Elmore MF (1986) Microbial growth patterns in a total parenteral nutrition formulation containing lipid emulsion. JPEN J Parenter Enter Nutr 10:494–497

    Article  CAS  Google Scholar 

  20. Maki DG, Martin WT (1975) Nationwide epidemic of septicemia caused by contaminated infusion products. IV. Growth of microbial pathogens in fluids for intravenous infusions. J Infect Dis 131:267–272

    Article  PubMed  CAS  Google Scholar 

  21. Del Castillo J, Lopez-Herce J, Cidoncha E et al (2008) Circuit life span in critically ill children on continuous renal replacement treatment: a prospective observational evaluation study. Crit Care 12:R93

    Article  PubMed Central  PubMed  Google Scholar 

  22. Su HM, Lin TH, Hsu PC et al (2013) Global left ventricular longitudinal systolic strain as a major predictor of cardiovascular events in patients with atrial fibrillation. Heart 99:1588–1596

    Article  PubMed  Google Scholar 

  23. Palomba H, de Castro I, Neto AL, Lage S, Yu L (2007) Acute kidney injury prediction following elective cardiac surgery: AKICS Score. Kidney Int 72:624–631

    Article  PubMed  CAS  Google Scholar 

  24. Rassi A Jr, Rassi A, Little WC et al (2006) Development and validation of a risk score for predicting death in Chagas’ heart disease. N Engl J Med 355:799–808

    Article  PubMed  CAS  Google Scholar 

  25. Sullivan LM, Massaro JM, D’Agostino RB Sr (2004) Presentation of multivariate data for clinical use: the Framingham study risk score functions. Stat Med 23:1631–1660

    Article  PubMed  Google Scholar 

  26. Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R (2003) Continuous is not continuous: the incidence and impact of circuit “down-time” on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med 29:575–578

    Article  PubMed  Google Scholar 

  27. Langenecker SA, Felfernig M, Werba A, Mueller CM, Chiari A, Zimpfer M (1994) Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration. Crit Care Med 22:1774–1781

    Article  PubMed  CAS  Google Scholar 

  28. Oude Van mans-van Straaten HM, Wester JPJ, de Pont ACJM, Schetz MRC (2006) Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based? Intensive Care Med 32:188–202

    Article  CAS  Google Scholar 

  29. Broder G, Weil MH (1964) Excess lactate: an index of reversibility of shock in human patients. Science 143:1457–1459

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The study was supported by the National Key Technology R&D Program (No. 2011BAI10B08), the National Clinical Key Specialty Construction Preparatory Projects, and, in part, by Guangdong Provincial Scientific Planning Project #2010B031600157. This work for Wang was also supported, in part, by the Robert Wood Johnson Foundation Nurse Faculty Scholars Program.

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wei Shi.

Additional information

Xia Fu and Xinling Liang have contributed equally to this work.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 39 kb)

Supplementary material 2 (DOC 72 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fu, X., Liang, X., Song, L. et al. Building and validation of a prognostic model for predicting extracorporeal circuit clotting in patients with continuous renal replacement therapy. Int Urol Nephrol 46, 801–807 (2014). https://doi.org/10.1007/s11255-014-0682-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-014-0682-5

Keywords

Navigation